These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
981 related articles for article (PubMed ID: 17958624)
1. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. Nnoruka EN; Chukwuka JC; Anisuiba B Int J Dermatol; 2007 Oct; 46 Suppl 2():14-8. PubMed ID: 17958624 [TBL] [Abstract][Full Text] [Related]
2. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon. Josephine M; Issac E; George A; Ngole M; Albert SE Int J Dermatol; 2006 Mar; 45(3):280-4. PubMed ID: 16533229 [TBL] [Abstract][Full Text] [Related]
3. Skin disease: clinical indicator of immune status in human immunodeficiency virus (HIV) infection. Raju PV; Rao GR; Ramani TV; Vandana S Int J Dermatol; 2005 Aug; 44(8):646-9. PubMed ID: 16101864 [TBL] [Abstract][Full Text] [Related]
4. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts. Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796 [TBL] [Abstract][Full Text] [Related]
5. Oro-facial lesions and CD4 counts associated with HIV/AIDS in an adult population in Oyo State, Nigeria. Adurogbangba MI; Aderinokun GA; Odaibo GN; Olaleye OD; Lawoyin TO Oral Dis; 2004 Nov; 10(6):319-26. PubMed ID: 15533205 [TBL] [Abstract][Full Text] [Related]
6. CD4+ T-lymphocytes cell counts in adults with human immunodeficiency virus infection at the medical department of a tertiary health institution in Nigeria. Ajayi AO; Ajayi EA; Fasakin KA Ann Afr Med; 2009; 8(4):257-60. PubMed ID: 20139549 [TBL] [Abstract][Full Text] [Related]
7. Mantoux reaction in patients with HIV-related pulmonary tuberculosis in Maiduguri, Nigeria. Yusuph H; Garbati MA; Gashau W Afr J Med Med Sci; 2005 Jun; 34(2):125-8. PubMed ID: 16749335 [TBL] [Abstract][Full Text] [Related]
8. Relationship between clinical conditions and CD4 counts in HIV-infected persons in Pune, Maharashtra, India. Ghate MV; Mehendale SM; Mahajan BA; Yadav R; Brahme RG; Divekar AD; Paranjape RS Natl Med J India; 2000; 13(4):183-7. PubMed ID: 11002684 [TBL] [Abstract][Full Text] [Related]
9. Neurological complications in patients with HIV/AIDS. Bolokadze N; Gabunia P; Ezugbaia M; Gatserelia L; Khechiashvili G Georgian Med News; 2008 Dec; (165):34-8. PubMed ID: 19124914 [TBL] [Abstract][Full Text] [Related]
10. Correlation of mucocutaneous manifestations of HIV-infected patients in an ART center with CD4 counts. Lahoti S; Rao K; Umadevi HS; Mishra L Indian J Dent Res; 2017; 28(5):549-554. PubMed ID: 29072219 [TBL] [Abstract][Full Text] [Related]
11. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
12. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P; Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells. French M; Keane N; McKinnon E; Phung S; Price P HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858 [TBL] [Abstract][Full Text] [Related]
14. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation. Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L; Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778 [TBL] [Abstract][Full Text] [Related]
15. Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts? Mbanya D; Assah F; Ndembi N; Kaptue L Int J Infect Dis; 2007 Mar; 11(2):157-60. PubMed ID: 16762583 [TBL] [Abstract][Full Text] [Related]
16. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy. D'Orsogna LJ; Krueger RG; McKinnon EJ; French MA AIDS; 2007 Aug; 21(13):1747-52. PubMed ID: 17690573 [TBL] [Abstract][Full Text] [Related]
17. Use of total lymphocyte count for monitoring response to antiretroviral therapy. Schreibman T; Friedland G Clin Infect Dis; 2004 Jan; 38(2):257-62. PubMed ID: 14699459 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of dermatological disorders in Thai HIV-infected patients correlated with different CD4 lymphocyte count statuses: a note on 120 cases. Wiwanitkit V Int J Dermatol; 2004 Apr; 43(4):265-8. PubMed ID: 15090008 [TBL] [Abstract][Full Text] [Related]
19. Lower Helicobacter pylori infection and peptic ulcer disease prevalence in patients with AIDS and suppressed CD4 counts. Cacciarelli AG; Marano BJ; Gualtieri NM; Zuretti AR; Torres RA; Starpoli AA; Robilotti JG Am J Gastroenterol; 1996 Sep; 91(9):1783-4. PubMed ID: 8792698 [TBL] [Abstract][Full Text] [Related]
20. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections. Wadhwa A; Kaur R; Bhalla P Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]